XARELTO · ReferencePrescription
RIVAROXABAN 20MG · TABLET · ORAL
XARELTO · ReferencePrescription
RIVAROXABAN 10MG · TABLET · ORAL
XARELTO · ReferencePrescription
RIVAROXABAN 2.5MG · TABLET · ORAL
XARELTO · ReferencePrescription
RIVAROXABAN 15MG · TABLET · ORAL
2026-03-24Labeling · Supplement 45 · standard — Label ↗AP 2025-06-17Labeling · Supplement 44 · standard — Letter ↗AP 2023-02-08Labeling · Supplement 41 · standard — Letter ↗AP 2022-03-01Labeling · Supplement 39 · standard — Letter ↗AP 2021-08-23Labeling · Supplement 37 · standard — Letter ↗AP 2021-01-28Labeling · Supplement 36 · standard — Letter ↗AP 2020-03-10Labeling · Supplement 35 · standard — Letter ↗AP 2019-11-15Labeling · Supplement 27 · standard — Letter ↗AP 2019-10-11Efficacy · Supplement 33 · standard — Label ↗AP 2019-08-23Labeling · Supplement 34 · standard — Letter ↗AP 2019-01-15Labeling · Supplement 30 · standard — Label ↗AP 2019-01-15Labeling · Supplement 32 · standard — Label ↗AP 2018-11-07Labeling · Supplement 29 · standard — Label ↗AP 2018-07-30Labeling · Supplement 28 · standard — Label ↗AP 2017-10-27Efficacy · Supplement 24 · priority — Label ↗AP 2017-06-28Labeling · Supplement 23 · standard — Label ↗AP 2017-02-10Labeling · Supplement 21 · standardAP
2016-08-25Labeling · Supplement 20 · standard — Letter ↗AP 2016-08-25Labeling · Supplement 19 · standard — Letter ↗AP 2016-08-17Labeling · Supplement 17 · standard — Letter ↗AP 2015-10-26Manufacturing (CMC) · Supplement 16 · standardAP
2015-05-05Manufacturing (CMC) · Supplement 14 · standardAP
2015-02-16Manufacturing (CMC) · Supplement 13 · standardAP
2015-01-15Labeling · Supplement 12 · standard — Letter ↗AP 2014-12-19Labeling · Supplement 15 · standard — Letter ↗AP 2014-09-15Manufacturing (CMC) · Supplement 11 · standard — Label ↗AP 2014-03-06Labeling · Supplement 9 · standard — Letter ↗AP 2014-02-13Labeling · Supplement 10 · standard — Label ↗AP 2014-01-07Labeling · Supplement 7 · standard — Label ↗AP 2013-03-01Efficacy · Supplement 4 · standard — Letter ↗AP 2013-01-31Manufacturing (CMC) · Supplement 6 · standardAP
2012-11-02Efficacy · Supplement 3 · priority — Label ↗AP 2012-11-02Efficacy · Supplement 1 · priority — Label ↗AP 2012-11-02Efficacy · Supplement 2 · priority — Letter ↗AP 2011-07-01Type 1 - New Molecular Entity · Original · standard — Letter ↗AP Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.